October 15 is Breast Cancer Awareness Day — a moment to honour the millions of lives affected by breast cancer and to reaffirm our commitment to advancing better treatments.
The global challenge remains immense:
→ 2.3 million women diagnosed worldwide in 2022
→ Breast cancer is still the most commonly diagnosed cancer among women
→ Survival rates differ greatly depending on access to care
→ By 2050, incidence and mortality are projected to rise by 40%
At Biokinetica, our oncology clinical trial portfolio includes dedicated breast cancer studies. Our contribution to this global effort:
🔬 Testing innovative therapies with the potential to transform treatment paradigms
📊 Generating high-quality data that advance global oncology research
💙 Enabling patients to access cutting-edge treatments through clinical trials
🌍 Partnering with leading pharmaceutical and biotech companies to bring hope closer to patients
